Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients

Mariela M. Lopez, Alexander Chase Castillo, Kyle Kaltwasser, Linda Phillips, Clayton L. Moliver

    Research output: Contribution to journalArticle

    8 Citations (Scopus)

    Abstract

    Background: Young female subjects are known to have the highest baseline menstrual hormone levels of any female age group. Studies have found an association between hormone levels and wound healing. This has been researched in the orthopedic, gynecologic, and dermatologic literature, and more recently, in young patients undergoing augmentation mammaplasty. The purpose of this study was to determine whether the timing of surgery relative to the menstrual cycle plays a role in surgical complications following bilateral reduction mammaplasty. Methods: All female patients aged 25 years or younger with a documented last menstrual cycle undergoing a bilateral reduction mammaplasty from 2005 to 2013 were reviewed. Surgical timing and postoperative complications relative to the last menstrual cycle were recorded. The preovulatory phase referred to days 1 to 14 after the patient's last menstrual cycle, whereas the postovulatory phase referred to days 15 to 28. Results: Forty-nine patients met inclusion criteria. Undergoing bilateral reduction mammaplasty during the postovulatory phase was associated with development of wound dehiscence and hypertrophic scarring (p <0.005), which were the most common postoperative complications. Surgery in the preovulatory or postovulatory phase did not affect hematoma, seroma, wound infection, or nipple-areolar complex necrosis rates (p > 0.05). Age, race/ethnicity, body mass index, large resection mass, and medical comorbidities did not affect wound dehiscence or scar hypertrophy rates (p > 0.05). Conclusions: Young patients undergoing bilateral reduction mammaplasty during the postovulatory phase of the menstrual cycle have an increased risk of wound healing issues and poor scarring. This may be attributable to hormonal fluxes occurring during this phase and the already high hormone levels in this population.

    Original languageEnglish (US)
    Pages (from-to)406-410
    Number of pages5
    JournalPlastic and Reconstructive Surgery
    Volume137
    Issue number2
    DOIs
    StatePublished - Feb 1 2016

    Fingerprint

    Mammaplasty
    Menstrual Cycle
    Wound Healing
    Breast
    Luteal Phase
    Cicatrix
    Hormones
    Follicular Phase
    Wounds and Injuries
    Hypertrophy
    Orthopedics
    Comorbidity
    Body Mass Index
    Age Groups
    Population

    ASJC Scopus subject areas

    • Surgery

    Cite this

    Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. / Lopez, Mariela M.; Castillo, Alexander Chase; Kaltwasser, Kyle; Phillips, Linda; Moliver, Clayton L.

    In: Plastic and Reconstructive Surgery, Vol. 137, No. 2, 01.02.2016, p. 406-410.

    Research output: Contribution to journalArticle

    Lopez, Mariela M. ; Castillo, Alexander Chase ; Kaltwasser, Kyle ; Phillips, Linda ; Moliver, Clayton L. / Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. In: Plastic and Reconstructive Surgery. 2016 ; Vol. 137, No. 2. pp. 406-410.
    @article{bb42b717c1544d6d8f5a14d285e113b0,
    title = "Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients",
    abstract = "Background: Young female subjects are known to have the highest baseline menstrual hormone levels of any female age group. Studies have found an association between hormone levels and wound healing. This has been researched in the orthopedic, gynecologic, and dermatologic literature, and more recently, in young patients undergoing augmentation mammaplasty. The purpose of this study was to determine whether the timing of surgery relative to the menstrual cycle plays a role in surgical complications following bilateral reduction mammaplasty. Methods: All female patients aged 25 years or younger with a documented last menstrual cycle undergoing a bilateral reduction mammaplasty from 2005 to 2013 were reviewed. Surgical timing and postoperative complications relative to the last menstrual cycle were recorded. The preovulatory phase referred to days 1 to 14 after the patient's last menstrual cycle, whereas the postovulatory phase referred to days 15 to 28. Results: Forty-nine patients met inclusion criteria. Undergoing bilateral reduction mammaplasty during the postovulatory phase was associated with development of wound dehiscence and hypertrophic scarring (p <0.005), which were the most common postoperative complications. Surgery in the preovulatory or postovulatory phase did not affect hematoma, seroma, wound infection, or nipple-areolar complex necrosis rates (p > 0.05). Age, race/ethnicity, body mass index, large resection mass, and medical comorbidities did not affect wound dehiscence or scar hypertrophy rates (p > 0.05). Conclusions: Young patients undergoing bilateral reduction mammaplasty during the postovulatory phase of the menstrual cycle have an increased risk of wound healing issues and poor scarring. This may be attributable to hormonal fluxes occurring during this phase and the already high hormone levels in this population.",
    author = "Lopez, {Mariela M.} and Castillo, {Alexander Chase} and Kyle Kaltwasser and Linda Phillips and Moliver, {Clayton L.}",
    year = "2016",
    month = "2",
    day = "1",
    doi = "10.1097/01.prs.0000475748.02721.3d",
    language = "English (US)",
    volume = "137",
    pages = "406--410",
    journal = "Plastic and Reconstructive Surgery",
    issn = "0032-1052",
    publisher = "Lippincott Williams and Wilkins",
    number = "2",

    }

    TY - JOUR

    T1 - Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients

    AU - Lopez, Mariela M.

    AU - Castillo, Alexander Chase

    AU - Kaltwasser, Kyle

    AU - Phillips, Linda

    AU - Moliver, Clayton L.

    PY - 2016/2/1

    Y1 - 2016/2/1

    N2 - Background: Young female subjects are known to have the highest baseline menstrual hormone levels of any female age group. Studies have found an association between hormone levels and wound healing. This has been researched in the orthopedic, gynecologic, and dermatologic literature, and more recently, in young patients undergoing augmentation mammaplasty. The purpose of this study was to determine whether the timing of surgery relative to the menstrual cycle plays a role in surgical complications following bilateral reduction mammaplasty. Methods: All female patients aged 25 years or younger with a documented last menstrual cycle undergoing a bilateral reduction mammaplasty from 2005 to 2013 were reviewed. Surgical timing and postoperative complications relative to the last menstrual cycle were recorded. The preovulatory phase referred to days 1 to 14 after the patient's last menstrual cycle, whereas the postovulatory phase referred to days 15 to 28. Results: Forty-nine patients met inclusion criteria. Undergoing bilateral reduction mammaplasty during the postovulatory phase was associated with development of wound dehiscence and hypertrophic scarring (p <0.005), which were the most common postoperative complications. Surgery in the preovulatory or postovulatory phase did not affect hematoma, seroma, wound infection, or nipple-areolar complex necrosis rates (p > 0.05). Age, race/ethnicity, body mass index, large resection mass, and medical comorbidities did not affect wound dehiscence or scar hypertrophy rates (p > 0.05). Conclusions: Young patients undergoing bilateral reduction mammaplasty during the postovulatory phase of the menstrual cycle have an increased risk of wound healing issues and poor scarring. This may be attributable to hormonal fluxes occurring during this phase and the already high hormone levels in this population.

    AB - Background: Young female subjects are known to have the highest baseline menstrual hormone levels of any female age group. Studies have found an association between hormone levels and wound healing. This has been researched in the orthopedic, gynecologic, and dermatologic literature, and more recently, in young patients undergoing augmentation mammaplasty. The purpose of this study was to determine whether the timing of surgery relative to the menstrual cycle plays a role in surgical complications following bilateral reduction mammaplasty. Methods: All female patients aged 25 years or younger with a documented last menstrual cycle undergoing a bilateral reduction mammaplasty from 2005 to 2013 were reviewed. Surgical timing and postoperative complications relative to the last menstrual cycle were recorded. The preovulatory phase referred to days 1 to 14 after the patient's last menstrual cycle, whereas the postovulatory phase referred to days 15 to 28. Results: Forty-nine patients met inclusion criteria. Undergoing bilateral reduction mammaplasty during the postovulatory phase was associated with development of wound dehiscence and hypertrophic scarring (p <0.005), which were the most common postoperative complications. Surgery in the preovulatory or postovulatory phase did not affect hematoma, seroma, wound infection, or nipple-areolar complex necrosis rates (p > 0.05). Age, race/ethnicity, body mass index, large resection mass, and medical comorbidities did not affect wound dehiscence or scar hypertrophy rates (p > 0.05). Conclusions: Young patients undergoing bilateral reduction mammaplasty during the postovulatory phase of the menstrual cycle have an increased risk of wound healing issues and poor scarring. This may be attributable to hormonal fluxes occurring during this phase and the already high hormone levels in this population.

    UR - http://www.scopus.com/inward/record.url?scp=84955581483&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84955581483&partnerID=8YFLogxK

    U2 - 10.1097/01.prs.0000475748.02721.3d

    DO - 10.1097/01.prs.0000475748.02721.3d

    M3 - Article

    C2 - 26818273

    AN - SCOPUS:84955581483

    VL - 137

    SP - 406

    EP - 410

    JO - Plastic and Reconstructive Surgery

    JF - Plastic and Reconstructive Surgery

    SN - 0032-1052

    IS - 2

    ER -